Literature DB >> 26401940

Basal Forebrain and Hippocampus as Predictors of Conversion to Alzheimer's Disease in Patients with Mild Cognitive Impairment - A Multicenter DTI and Volumetry Study.

Katharina Brueggen1, Martin Dyrba1,2, Frederik Barkhof3, Lucrezia Hausner4, Massimo Filippi5, Peter J Nestor6, Karlheinz Hauenstein7, Stefan Klöppel8, Michel J Grothe1, Elisabeth Kasper9, Stefan J Teipel1,9.   

Abstract

BACKGROUND: Hippocampal grey matter (GM) atrophy predicts conversion from mild cognitive impairment (MCI) to Alzheimer's disease (AD). Pilot data suggests that mean diffusivity (MD) in the hippocampus, as measured with diffusion tensor imaging (DTI), may be a more accurate predictor of conversion than hippocampus volume. In addition, previous studies suggest that volume of the cholinergic basal forebrain may reach a diagnostic accuracy superior to hippocampal volume in MCI.
OBJECTIVE: The present study investigated whether increased MD and decreased volume of the hippocampus, the basal forebrain and other AD-typical regions predicted time to conversion from MCI to AD dementia.
METHODS: 79 MCI patients with DTI and T1-weighted magnetic resonance imaging (MRI) were retrospectively included from the European DTI Study in Dementia (EDSD) dataset. Of these participants, 35 converted to AD dementia after 6-46 months (mean: 21 months). We used Cox regression to estimate the relative conversion risk predicted by MD values and GM volumes, controlling for age, gender, education and center.
RESULTS: Decreased GM volume in all investigated regions predicted an increased risk for conversion. Additionally, increased MD in the right basal forebrain predicted increased conversion risk. Reduced volume of the right hippocampus was the only significant predictor in a stepwise model combining all predictor variables.
CONCLUSION: Volume reduction of the hippocampus, the basal forebrain and other AD-related regions was predictive of increased risk for conversion from MCI to AD. In this study, volume was superior to MD in predicting conversion.

Entities:  

Keywords:  Alzheimer’s disease; Diffusion tensor imaging; Mild Cognitive Impairment; atrophy; basal forebrain; cholinergic; early diagnosis; magnetic resonance imaging

Mesh:

Year:  2015        PMID: 26401940     DOI: 10.3233/JAD-150063

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  21 in total

1.  Translation of imaging biomarkers from clinical research to healthcare.

Authors:  Ingo Kilimann; Jochen René Thyrian; Wolfgang Hoffmann; Stefan J Teipel
Journal:  Z Gerontol Geriatr       Date:  2017-04-12       Impact factor: 1.281

2.  Genetic and environmental influences on mean diffusivity and volume in subcortical brain regions.

Authors:  Nathan A Gillespie; Michael C Neale; Donald J Hagler; Lisa T Eyler; Christine Fennema-Notestine; Carol E Franz; Michael J Lyons; Linda K McEvoy; Anders M Dale; Matthew S Panizzon; William S Kremen
Journal:  Hum Brain Mapp       Date:  2017-02-27       Impact factor: 5.038

3.  Hippocampal volume and integrity as predictors of cognitive decline in intact elderly.

Authors:  Davide Bruno; Adam Ciarleglio; Michel J Grothe; Jay Nierenberg; Alvin H Bachman; Stefan J Teipel; Eva Petkova; Babak A Ardekani; Nunzio Pomara
Journal:  Neuroreport       Date:  2016-08-03       Impact factor: 1.837

4.  Neurobiological substrates underlying the effect of genomic risk for depression on the conversion of amnestic mild cognitive impairment.

Authors:  Jiayuan Xu; Qiaojun Li; Wen Qin; Mulin Jun Li; Chuanjun Zhuo; Huaigui Liu; Feng Liu; Junping Wang; Gunter Schumann; Chunshui Yu
Journal:  Brain       Date:  2018-12-01       Impact factor: 13.501

Review 5.  Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology.

Authors:  Harald Hampel; Nicola Toschi; Claudio Babiloni; Filippo Baldacci; Keith L Black; Arun L W Bokde; René S Bun; Francesco Cacciola; Enrica Cavedo; Patrizia A Chiesa; Olivier Colliot; Cristina-Maria Coman; Bruno Dubois; Andrea Duggento; Stanley Durrleman; Maria-Teresa Ferretti; Nathalie George; Remy Genthon; Marie-Odile Habert; Karl Herholz; Yosef Koronyo; Maya Koronyo-Hamaoui; Foudil Lamari; Todd Langevin; Stéphane Lehéricy; Jean Lorenceau; Christian Neri; Robert Nisticò; Francis Nyasse-Messene; Craig Ritchie; Simone Rossi; Emiliano Santarnecchi; Olaf Sporns; Steven R Verdooner; Andrea Vergallo; Nicolas Villain; Erfan Younesi; Francesco Garaci; Simone Lista
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

6.  Influence of Small Vessel Disease and Microstructural Integrity on Neurocognitive Functioning in Older Individuals: The DANTE Study Leiden.

Authors:  J E F Moonen; J C Foster-Dingley; A A van den Berg-Huijsmans; W de Ruijter; A J M de Craen; J van der Grond; R C van der Mast
Journal:  AJNR Am J Neuroradiol       Date:  2016-09-22       Impact factor: 3.825

Review 7.  Dysfunctional Sensory Modalities, Locus Coeruleus, and Basal Forebrain: Early Determinants that Promote Neuropathogenesis of Cognitive and Memory Decline and Alzheimer's Disease.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2016-06-23       Impact factor: 3.911

8.  Predicting Imminent Progression to Clinically Significant Memory Decline Using Volumetric MRI and FDG PET.

Authors:  Cynthia M Stonnington; Yinghua Chen; Cary R Savage; Wendy Lee; Robert J Bauer; Sameen Sharieff; Pradeep Thiyyagura; Gene E Alexander; Richard J Caselli; Dona E C Locke; Eric M Reiman; Kewei Chen
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

9.  Neuropsychiatric symptoms of cholinergic deficiency occur with degradation of the projections from the nucleus basalis of Meynert.

Authors:  Jan Willem van Dalen; Matthan W A Caan; Willem A van Gool; Edo Richard
Journal:  Brain Imaging Behav       Date:  2017-12       Impact factor: 3.978

10.  Diffusion MRI detects basal forebrain cholinergic abnormalities in the 3xTg-AD mouse model of Alzheimer's disease.

Authors:  Maria Fatima Falangola; Xingju Nie; Ralph Ward; Siddhartha Dhiman; Joshua Voltin; Paul J Nietert; Jens H Jensen
Journal:  Magn Reson Imaging       Date:  2021-07-03       Impact factor: 2.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.